From Biopsy to Pathology: A Retrospective Cohort Study of Predictors of Gleason Score Upgrading in Grade Group 1 Prostate Cancer
HSIAO-CHUN SU
, 
YUNG-CHUN SU
, 
HSIANG-YING LEE
, 
YUNG-SHUN JUAN
, 
WEN‑JENG WU
 and 
KEVIN LU
Cancer Diagnosis & Prognosis Nov-Dec; 6(6): 1005-1015 DOI: 10.21873/cdp.10603
Intramuscular Myxoma of the Shoulder in Neurofibromatosis Type 1
REINHARD E. FRIEDRICH
, 
CATENA KRESBACH
 and 
CHRISTIAN HAGEL
Cancer Diagnosis & Prognosis Nov-Dec; 6(6): 1016-1023 DOI: 10.21873/cdp.10604
Granular Cell Tumor of the Gallbladder: A Rare Entity
ANJA STADNIK
, 
ARIJANA PAČIĆ
, 
KAROLINA KRSTANAC
, 
KRISTINA LALIĆ
 and 
DOMAGOJ VERGLES
Cancer Diagnosis & Prognosis Nov-Dec; 6(6): 1024-1028 DOI: 10.21873/cdp.10605
Primary Male Appendiceal Choriocarcinoma With Background of Low-Grade Appendiceal Mucinous Neoplasm: Diagnostic Challenges and Poor Prognosis
ALICIA FENG
, 
KATHERINE Y. BAI
, 
YING GAO
, 
RUOHAO FAN
, 
YUANPEI LI
 and 
JINPING LAI
Cancer Diagnosis & Prognosis Nov-Dec; 6(6): 1029-1035 DOI: 10.21873/cdp.10606
Merkel Cell Polyomavirus-Negative Merkel Cell Carcinoma Presenting in the Parotid Gland: Precise Diagnosis and Complete Pathological Response to Nivolumab
ARTHUR Z. LI
, 
DANIEL I. CHUNG
, 
SHANNON M. POTI
, 
THOMAS R. O’TOOLE
 and 
JINPING LAI
Cancer Diagnosis & Prognosis Nov-Dec; 6(6): 1036-1042 DOI: 10.21873/cdp.10607
Prognostic Impact of Nectin4 and IRF6 Expression in Patients Undergoing Radical Cystectomy for Muscle-Invasive Bladder Cancer
DOMINIK ENDERLIN
, 
MARIA GLOOR
, 
UWE BIERI
, 
ALEKHYA MAZUMDAR
, 
SOUZAN SALEMI
, 
NIELS RUPP
, 
HOLGER MOCH
, 
DANIEL EBERLI
 and 
CÉDRIC POYET
Cancer Diagnosis & Prognosis Nov-Dec; 6(6): 947-960 DOI: 10.21873/cdp.10597
Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: A Single-institution Retrospective Study
ATSUTO KATANO
 and 
HIDEOMI YAMASHITA
Cancer Diagnosis & Prognosis Nov-Dec; 6(6): 961-968 DOI: 10.21873/cdp.10598
Baseline Peripheral Neuropathy Predicts Clinically Significant Neuropathy During Paclitaxel Treatment Following Oxaliplatin-based Chemotherapy
AIKO TOMIUCHI
, 
MICHIO KIMURA
, 
YOSHIAKI IKEDA
 and 
EISEKI USAMI
Cancer Diagnosis & Prognosis Nov-Dec; 6(6): 969-976 DOI: 10.21873/cdp.10599
Larger Non-metastatic No. 8 Lymph Node Size Is Associated With Favorable Prognosis After Pancreaticoduodenectomy for Pancreatic Cancer
TARO SAKAMOTO
, 
TAKESHI GOCHO
, 
MASASHI TSUNEMATSU
, 
YOSHIHIRO SHIRAI
, 
NORIMITSU OKUI
, 
RYOGA HAMURA
, 
YOSHIAKI TANJI
, 
TAKASHI AIDA
, 
YUTA YAMADA
, 
KOHEI OKAZAKI
, 
YUTO YAMAHATA
, 
KENEI FURUKAWA
 and 
TORU IKEGAMI
Cancer Diagnosis & Prognosis Nov-Dec; 6(6): 977-987 DOI: 10.21873/cdp.10600
Association Between S-1 Treatment Duration and Disease Control in Advanced Non-small-cell Lung Cancer
YUTAKA TAKAHARA
, 
RYUDAI ABE
, 
SUMITO NAGAE
, 
TAKUYA TANAKA
, 
YOKO ISHIGE
, 
IKUYO SHIONOYA
, 
KOUICHI YAMAMURA
 and 
MASAHARU IGUCHI
Cancer Diagnosis & Prognosis Nov-Dec; 6(6): 988-995 DOI: 10.21873/cdp.10601
Prognostic Relevance of Surface α-Enolase (ENO1) in Patients With Lung Adenocarcinoma
YU-SEN LIN
, 
TE-HONG CHEN
, 
YUAN-YAO TSAI
, 
TAO-WEI KE
, 
CHI-HSIEN HUANG
, 
CHIA-YU TSAI
, 
WILLIAM TZU-LIANG CHEN
, 
K.S. CLIFFORD CHAO
 and 
KEVIN CHIH-YANG HUANG
Cancer Diagnosis & Prognosis Nov-Dec; 6(6): 996-1004 DOI: 10.21873/cdp.10602
Malignant Myoepithelioma Arising from the Upper Arm With Brachial Plexus Involvement: A Rare Case
HAYATO TATSUMI
, 
TOSHIHIRO MATSUO
, 
TAKASHI NISHISAKA
, 
YUI HATTORI
, 
KOJI NISHIDA
, 
RYOUSUKE MATSUSHITA
, 
MASAHIRO YOSHIKAWA
, 
SATOSHI AKI
 and 
NOBUO ADACHI
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 942-946 DOI: 10.21873/cdp.10596
Immune Checkpoint Inhibitor Resistance in Rectal Adenocarcinoma Containing a Mismatch Repair Deficiency Component: A Case Report
KOHEI OKURA
, 
HARUKA TAKENAKA
, 
HIROSHI FUJITA
, 
NORIHISA HANADA
 and 
YOSHIHIRO KOMOHARA
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 934-941 DOI: 10.21873/cdp.10595
Jejunal Mixed Adenoneuroendocrine Carcinoma (MANEC) With a Novel PTPRK-RSPO3 Fusion Initially Presenting as a Large Ovarian Mass: Diagnostic Challenges and Poor Prognosis
RAN WANG
 and 
JINPING LAI
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 928-933 DOI: 10.21873/cdp.10594
Two Cases of Uterine Small-cell Neuroendocrine Carcinoma With Somatostatin-receptor-type-2 (SSTR2) Expression and Minor Components of Endocervical Adenocarcinoma
MASAMICHI BAMBA
, 
TOMO NAMURA
, 
TOSHIKAZU KATO
, 
MASANORI SHIOHARA
, 
KENJI ISOGAWA
, 
MAO UEMURA
, 
SHIRO WAKINOUE
, 
HIROKO YOMO
, 
TETSUYA NAKAGAWA
, 
TETSUYA KATSUMORI
, 
RYOJI KUSHIMA
 and 
SUZUKO MORITANI
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 918-927 DOI: 10.21873/cdp.10593
Prognostic Significance of Number of Liver Metastases in Patients With Advanced Pancreatic Cancer Receiving Nab-paclitaxel Plus Gemcitabine
KIYOTSUGU IEDE
, 
TERUMASA YAMADA
, 
HIROTOSHI TAKAYAMA
, 
MASARU SASAKI
, 
TOMO ISHIDA
, 
MASAFUMI YAMASHITA
, 
YUKAKO MOKUTANI
, 
TSUKASA TANIDA
, 
JIN MATSUYAMA
, 
KEN NAKATA
 and 
SHUSEI TOMINAGA
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 909-917 DOI: 10.21873/cdp.10592
Preoperative Magnetic Resonance Imaging Findings of the Transition Zone Predict Incidental Prostate Cancer in HoLEP
TOSHIKI ITO
, 
YUSAKU HISAMATSU
, 
SHUHEI MIZUTANI
, 
TAKASHI KODAMA
, 
SHINYA WATANABE
, 
HIROYUKI AMANO
 and 
TERUO INAMOTO
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 900-908 DOI: 10.21873/cdp.10591
First-line Enfortumab Vedotin Plus Pembrolizumab in Platinum-ineligible Advanced Urothelial Carcinoma
GO KANEKO
, 
DAISUKE IGARASHI
 and 
SUGURU SHIROTAKE
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 890-899 DOI: 10.21873/cdp.10590
Real-world Outcomes of First-line Platinum-based Chemotherapy in Patients Aged 80 Years or Older With Metastatic Urothelial Carcinoma
AKINORI MINATO
, 
KAZUMASA JOJIMA
, 
YUTO TSUBONUMA
, 
YUI MIZUSHIMA
, 
YOSHIHIRO SUGITA
, 
TAKUO MATSUKAWA
, 
IKKO TOMISAKI
 and 
EIJI KASHIWAGI
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 882-889 DOI: 10.21873/cdp.10589
Prognostic Impact of Recurrence Location in Locally Recurrent Rectal Cancer: A Single-Center Retrospective Study
SHO NAMBARA
, 
KOJI ANDO
, 
TETSURO KAWAZOE
, 
SHOTARO KOREHISA
, 
YASUO TSUDA
, 
TOMONORI NAKANOKO
, 
EIJI OKI
 and 
TOMOHARU YOSHIZUMI
Cancer Diagnosis & Prognosis Sep-Oct; 6(5): 872-881 DOI: 10.21873/cdp.10588